Corteva (NYSE:CTVA) Price Target Increased to $58.00 by Analysts at Barclays

Corteva (NYSE:CTVA - Get Free Report) had its target price raised by investment analysts at Barclays from $55.00 to $58.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Barclays's price objective would suggest a potential upside of 1.47% from the company's current price.

Other analysts have also issued research reports about the stock. BNP Paribas upgraded shares of Corteva from an "underperform" rating to a "neutral" rating and set a $53.00 price target for the company in a research note on Friday, February 2nd. UBS Group cut their target price on shares of Corteva from $65.00 to $64.00 and set a "buy" rating on the stock in a research note on Thursday, January 11th. Wells Fargo & Company lifted their price target on Corteva from $54.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, February 2nd. Royal Bank of Canada boosted their price objective on Corteva from $56.00 to $64.00 and gave the company an "outperform" rating in a report on Friday, February 2nd. Finally, Oppenheimer increased their target price on Corteva from $60.00 to $62.00 and gave the stock an "outperform" rating in a report on Friday, February 2nd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of "Moderate Buy" and a consensus price target of $63.43.

Corteva Trading Down 0.6 %

Corteva stock traded down $0.36 during trading on Wednesday, hitting $57.16. The company's stock had a trading volume of 2,133,238 shares, compared to its average volume of 3,724,262. The stock has a market capitalization of $39.95 billion, a price-to-earnings ratio of 56.07, a P/E/G ratio of 1.48 and a beta of 0.77. The stock's fifty day moving average is $54.84 and its 200 day moving average is $50.08. Corteva has a 1-year low of $43.22 and a 1-year high of $63.37. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The firm had revenue of $3.71 billion for the quarter, compared to analysts' expectations of $3.54 billion. During the same period in the previous year, the company posted $0.16 earnings per share. As a group, equities research analysts predict that Corteva will post 2.87 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CTVA. Kingsview Wealth Management LLC raised its stake in Corteva by 2.0% in the third quarter. Kingsview Wealth Management LLC now owns 7,660 shares of the company's stock valued at $438,000 after purchasing an additional 153 shares in the last quarter. Centaurus Financial Inc. boosted its holdings in Corteva by 4.9% in the first quarter. Centaurus Financial Inc. now owns 3,867 shares of the company's stock valued at $233,000 after acquiring an additional 182 shares during the last quarter. Laidlaw Wealth Management LLC boosted its holdings in Corteva by 5.1% in the fourth quarter. Laidlaw Wealth Management LLC now owns 3,968 shares of the company's stock valued at $233,000 after acquiring an additional 194 shares during the last quarter. Arcataur Capital Management LLC boosted its holdings in Corteva by 2.4% in the third quarter. Arcataur Capital Management LLC now owns 8,598 shares of the company's stock valued at $440,000 after acquiring an additional 200 shares during the last quarter. Finally, Union Savings Bank boosted its holdings in Corteva by 58.5% in the third quarter. Union Savings Bank now owns 577 shares of the company's stock valued at $30,000 after acquiring an additional 213 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.